US Stock MarketDetailed Quotes

AKRO Akero Therapeutics

Watchlist
  • 32.730
  • +1.530+4.90%
Close Nov 22 16:00 ET
  • 32.200
  • -0.530-1.62%
Post 20:01 ET
2.28BMarket Cap-8658P/E (TTM)

Akero Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akero Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Akero Therapeutics Earnings Reports

  • Akero Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8 07:35 ET

  • Akero Therapeutics | 8-K: Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 8 07:25 ET

  • Akero Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 07:32 ET

  • Akero Therapeutics | 8-K: Akero Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 9 07:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data